Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Soleno Therapeutics (SLNO) Accumulated Depreciation & Amortization (2016 - 2025)

Soleno Therapeutics (SLNO) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $123000.0 as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $123000.0; the TTM value through Dec 2025 reached $123000.0, changed N/A, while the annual FY2025 figure was $123000.0, N/A changed from the prior year.
  • Accumulated Depreciation & Amortization hit $123000.0 in Q4 2025 for Soleno Therapeutics, up from $31000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $123000.0 in Q4 2025 and bottomed at $123000.0 in Q4 2025.